NOVN Novartis AG

118.38CHF+1.63%Mkt Cap: 252.68B $P/E: 22.19

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…

Key Statistics

Company
Market Cap252.68B USD
Enterprise Value300.08B USD
Revenue (TTM)64.70B USD
Gross Profit49.05B USD
Net Income (TTM)15.96B USD
Revenue/Share29.64 CHF
Last Price118.38 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees75.3K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012005267
Valuation
P/E (Trailing)22.19
P/E (Forward)14.18
PEG3.26
EV/EBITDA11.38
EV/Revenue4.64
P/S3.90
P/B6.45
EPS (TTM)5.25
EPS (Forward)8.20
52W Range
97.0560% of range132.68
52W High132.68 CHF
52W Low97.05 CHF
Profitability
Gross Margin75.83%
Oper. Margin34.62%
EBITDA Margin40.74%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth0.80%
Earnings Growth-17.00%
Cash Flow & Leverage
Operating CF21.85B USD
CapEx (TTM)4.45B USD
FCF Margin20.99%
FCF Yield5.38%
Net Debt47.25B USD
Net Debt/EBITDA1.79
Balance Sheet
Debt/Equity0.77
Current Ratio0.86
Quick Ratio0.55
Book Value/Sh18.04 CHF
Cash/Share4.01 CHF
Dividends
Fwd Div Rate3.70 CHF
Trail. Div Rate4.67 CHF
Div. Yield3.18%
5Y Avg Yield3.53%
Payout Ratio68.92%
Ex-Div DateMar 10, 2026
Pay DateMar 13, 2025
Splits
Last Split40:1
Split DateMay 7, 2001
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)125.78 CHF
Upside (mean)+6.3%
Target Range100.38 CHF – 151.04 CHF
100.38+6.3% to mean151.04
# Analysts22
Ownership
Shares Out.1.90B
Float1.86B
Insiders2.11%
Institutions46.04%
Technical
SMA 50122.57 (-3.4%)
SMA 200120.39 (-1.7%)
Beta0.49
S&P 52W Chg14.58%
Avg Vol (30d)3.41M
Avg Vol (10d)3.02M
Technical Indicators
RSI (14)42.2
MACD-1.0867
MACD Signal-1.3897
MACD Hist.+0.3030
BB Upper122.29 CHF
BB Middle116.15 CHF
BB Lower110.01 CHF
BB Width10.57%
ATR (14)2.603 CHF
Vol Ratio (20d)0.63x